AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 33069624
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of microUS-targeted and randomized biopsies
Trial: 33109926
Drug: Placebo groups
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo groups (informed that the application of an inert cream would reduce pain)
Trial: 33109926
Drug: Nocebo groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nocebo groups (informed that the application of an inert cream would amplify pain)
Trial: 36446950
Drug: Aspirin (loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (loading and maintenance doses)
Trial: 35176208
Drug: Drugs with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drugs with anticholinergic properties (DAPs) prescribed to patients
Trial: 35664760
Drug: supplemental home
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: supplemental home parenteral nutrition (sHPN)
Trial: 34836211
Drug: TRX suspension
RxNorm normalized name: TRX-518
DrugBank: TRX-518 (DB17534)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TRX suspension training + placebo (TP)
Trial: 34836211
Drug: TRX suspension
RxNorm normalized name: TRX-518
DrugBank: TRX-518 (DB17534)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TRX suspension training + taurine supplementation (TT)
Trial: 34937416
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as Usual (CON)
Trial: 616389141
Drug: 1 x
RxNorm normalized name: Black Cohosh 1 X Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 x 3 soft capsules of BCSO (0.5 ml each)
Trial: 616389141
Drug: 2 x
RxNorm normalized name: anti-HER2 x HER2 ADC
DrugBank: Zanidatamab zovodotin (DB15472)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 x 3 soft capsules of BCSO (0.5 ml each)
Trial: 616389141
Drug: 3 x
RxNorm normalized name: Xenon (133 xe)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 x 3 soft capsules of BCSO (0.5 ml each)
Trial: 38627631
Drug: Cilostazol (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cilostazol (200 mg)
Trial: 36062966
Drug: Daily GH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily GH (Norditropin; 0.034 mg/kg/d)
Trial: 37406251
Drug: Somapacitan (0.16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Somapacitan (0.16 mg/kg/wk)
Trial: 33403759
Drug: Dexmedetomidine (DEX)
DrugBank: Dexmedetomidine (DB00633)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dexmedetomidine (DEX) infusion during OLDH
Trial: 32589506
Drug: Volanesorsen 300
RxNorm normalized name: Volanesorsen
DrugBank: Volanesorsen (DB15067)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Volanesorsen 300 mg SC
Trial: 32589506
Drug: Volanesorsen 300
RxNorm normalized name: Volanesorsen
DrugBank: Volanesorsen (DB15067)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Volanesorsen 300 mg IV
Trial: 35195075
Drug: Endoscopic balloon
RxNorm normalized name: CATHETER,BALLOON
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endoscopic balloon dilatation combined with submucosal injection of 40 mg prednisolone
Trial: 32380660
Drug: Intravenous iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous iron (1 g ferric carboxymaltose, n = 86)
Trial: 32380660
Drug: Oral iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral iron supplementation (10 g iron fumarate, 100 capsules, n = 90)
Trial: 36177443
Drug: Glibenclamide (1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glibenclamide (1.25 mg, 3 times/day) with standard care
Trial: 34157996
Drug: Platinum-containing dual-drug
RxNorm normalized name: platinum
DrugBank: Platinum (DB12257)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Platinum-containing dual-drug chemotherapy
Trial: 32091594
Drug: Single-dose bivalent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose bivalent HPV vaccine
Trial: 32091594
Drug: Two-dose bivalent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two-dose bivalent HPV vaccine
Trial: 32091594
Drug: Three-dose bivalent
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three-dose bivalent HPV vaccine
Trial: 35872530
Drug: Olaparib 200
RxNorm normalized name: Olaparib
DrugBank: Olaparib (DB09074)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Olaparib 200 mg three times a day (TDS)
Trial: 32283944
Drug: Step 2
RxNorm normalized name: STEP 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Step 2 maintenance treatment
Trial: 36110981
Drug: Sports dance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sports dance exercises for 20-30 minutes, once a day initially, then twice a day for 180 days of continuous rehabilitation and exercise therapy.
Trial: 37337261
Drug: Treatment As
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment As Usual (TAU) alone
Trial: 35260342
Drug: Cetuximab (loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetuximab (loading dose 400 mg/m2 day 1; subsequent weekly 250 mg/m2 doses until two weeks postradiotherapy) + Cisplatin (75 mg/m2) + Pemetrexed (500 mg/m2) + Radiotherapy (maximally 66 Gy starting on day 22)
Trial: 32338756
Drug: Red meat
RxNorm normalized name: acid red 35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Red meat consumption more than twice a week for dinner
Trial: 33259976
Drug: Lidocaine throat
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lidocaine throat spray
Trial: 33259976
Drug: Lidocaine throat
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lidocaine throat spray and nebulized lidocaine
Trial: 36038633
Drug: Spa therapy
RxNorm normalized name: Broda Acne Spa
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spa therapy
Trial: 33707305
Drug: GLP-1 receptor
RxNorm normalized name: GLP-1 receptor agonist
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GLP-1 receptor agonists (GLP-1RAs)
Trial: 35775451
Drug: Sodium‐glucose cotransporter‐2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium‐glucose cotransporter‐2 inhibitors (SGLT2is)
Trial: 33818933
Drug: Alpha-blockers and
RxNorm normalized name: ALPHA BLOCKERS/RELATED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alpha-blockers and fluoroquinolones (control group)
Trial: 38847412
Drug: Rocuronium 0.9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rocuronium 0.9 mg/kg
Trial: 36296952
Drug: Fruits and
RxNorm normalized name: Aminobenzoic Acid/Ascorbic Acid/Biotin/Calcium/Cholecalciferol/Choline Bitartrate/Copper/Cyanocobalamin/Folic Acid/Inositol/Iodine/Iron/Magnesium/Manganese/Niacin/Pantothenic Acid/Phosphorus/Pyridoxine/Riboflavin/Thiamine/Vitamin A/Vitamin E/Zinc 5 MG-180 MG-300 MCG-120 MG-30 MCG-5 MG-2 MG-18 MCG-800 MCG-5 MG-150 MCG-18 MG-100 MG-2 MG-20 MG-30 MG-15 MG-2 MG-5.1 MG-4.5 MG-2250 MCG-7 MG-5 MG Oral Tablet [MEGAVITE WITH FRUITS AND VEGGIES]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fruits and vegetables containing phenylalanine 76−100 mg/100 g, additional intake of 50 mg/day and then 100 mg/day
Trial: 36296952
Drug: Milk protein
RxNorm normalized name: Milk protein
DrugBank: Casein (DB10516)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milk protein sources, additional intake of 50 mg/day and then 100 mg/day
Trial: 32032651
Drug: Antibiotic prophylaxis
RxNorm normalized name: STONE PROPHYLAXIS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic prophylaxis (after correction for confounders)
Trial: 36108767
Drug: N-acetylcysteine combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine combined with insulin
Trial: 34245368
Drug: Chlorpheniramine (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorpheniramine (0.1 mg/kg in 100 ml normal saline)
Trial: 34245368
Drug: Control (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (100 ml normal saline)
Trial: 34157772
Drug: Mozart's double
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mozart's double piano sonata exposure for 14 days, twice per day
Trial: 33046607
Drug: Multistrain probiotics
RxNorm normalized name: Rezyst Probiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multistrain probiotics capsules (n = 34)
Trial: 33259163
Drug: Acid suppression
RxNorm normalized name: Buckley's Cough Suppressant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acid suppression alone (4 weeks' proton pump inhibitor [PPI])
Trial: 33259163
Drug: Both treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatment groups (PPI + feeding modifications and PPI alone)
Trial: 33259163
Drug: Infants with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infants with continued PPI therapy
Trial: 35351537
Drug: Distance-guided deep
RxNorm normalized name: Deep Sea
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Distance-guided deep learning method for dose prediction
Trial: 33091520
Drug: Bone marrow
RxNorm normalized name: bone marrow
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bone marrow mononuclear cell (BM MNC) therapy
Trial: 36029019
Drug: Screening for
RxNorm normalized name: SUN PROTECTANTS/SCREENS,TOPICAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Screening for cardiovascular disease using low-dose computed tomography, limb blood pressure measurement, telemetric assessment of heart rhythm, cholesterol and HgbA1c measurements.
Trial: 33322192
Drug: Combined preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined preparation of brimonidine and timolol BID
Trial: 33322192
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no topical hypotensive treatment)
Trial: 33209881
Drug: Apatinib (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Apatinib (500 mg/day)
Trial: 33840725
Drug: Treatment compliance
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment compliance
Trial: 32325006
Drug: Instagram posts
RxNorm normalized name: post oak pollen extract
DrugBank: Quercus stellata pollen (DB10888)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Instagram posts regarding antidepressant use
Trial: 34732660
Drug: Combination treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination treatment (COM) - MET 500 mg TID, exenatide 2 mg QW
Trial: 35362766
Drug: Salmon fish
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmon fish protein supplement
Trial: 35691568
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg empagliflozin
Trial: 35395957
Drug: Placebo, twice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo, twice daily for 14 days
Trial: 34536993
Drug: Ultrasound-guided bilateral
RxNorm normalized name: ULTRASOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound-guided bilateral superficial cervical plexus block (BSCPB) with 7.5 ml of ropivacaine 0.5% on each side
Trial: 32933552
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment for COVID-19
Trial: 35202848
Drug: Metformin (25mg/cat
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (25mg/cat PO/q24h for 30 days)
Trial: 35202848
Drug: Methylprednisolone acetate
RxNorm normalized name: methylprednisolone acetate
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylprednisolone acetate (20 mg intramuscularly)
Trial: 35295331
Drug: Carbocysteine oral
RxNorm normalized name: carbocysteine Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbocysteine oral solution (mint taste)
Trial: 35295331
Drug: Carbocysteine oral
RxNorm normalized name: carbocysteine Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbocysteine oral solution (strawberry taste)
Trial: 33277607
Drug: 810 nm
RxNorm normalized name: NM-004
DrugBank: NM-004 (DB18066)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 810 nm diode laser application as an adjunct to non-surgical periodontal therapy (NPT)
Trial: 33277607
Drug: Non-surgical periodontal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-surgical periodontal therapy (NPT) without diode laser
Trial: 38046082
Drug: Early goal-directed
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Early goal-directed therapy
Trial: 36345020
Drug: Radial extracorporeal
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Radial extracorporeal shock wave therapy (ESWT)
Trial: 36345020
Drug: Sham extracorporeal
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sham extracorporeal shock wave therapy (sham‐ESWT)
Trial: 35357564
Drug: Dopaminergic medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dopaminergic medication
Trial: 32192595
Drug: Dienogest (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dienogest (1 mg/day, orally)
Trial: 34018147
Drug: Intensive statin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive statin regimen (40 mg/day atorvastatin)
Trial: 34515341
Drug: Reflexology (higher
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reflexology (higher dose after nonresponse)
Trial: 34515341
Drug: Meditative practices
RxNorm normalized name: benzalkonium chloride Topical Foam [Meditize]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meditative practices (higher dose after nonresponse)
Trial: 32220916
Drug: liraglutide 1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: liraglutide 1.2 mg plus canagliflozin 100 mg (CANA/LIRA)
Trial: 39262902
Drug: MDMA-assisted therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MDMA-assisted therapy (MDMA-AT)
Trial: 33642523
Drug: SO‐1105 (Miconazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SO‐1105 (Miconazole Mucoadhesive Tablets)
Trial: 32677897
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment (Control group, n=118)
Trial: 33731291
Drug: Traditional dorsal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional dorsal digital nerve block (two-injection)
Trial: 33731291
Drug: Subcutaneous volar
RxNorm normalized name: Polar Freeze
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous volar nerve block
Trial: 36349596
Drug: Transdermal estradiol
RxNorm normalized name: estradiol Transdermal System
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal estradiol (2 mg) and intranasal oxytocin (24 IU)
Trial: 36349596
Drug: Transdermal placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal placebo and intranasal oxytocin
Trial: 36349596
Drug: Transdermal estradiol
RxNorm normalized name: estradiol Transdermal System
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal estradiol and intranasal placebo
Trial: 36349596
Drug: Transdermal placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal placebo and intranasal placebo
Trial: 34901264
Drug: IV hydrocortisone
RxNorm normalized name: Hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: IV hydrocortisone administration prior to hemodialysis for 3 consecutive sessions
Trial: 34901264
Drug: Placebo (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (5 ml saline) administered during 3 intervention-free sessions
Trial: 32108732
Drug: Topical estriol
RxNorm normalized name: Estriol
DrugBank: Estriol (DB04573)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical estriol (E) - vaginal cream, daily application, 0.5 mg/d
Trial: 35062340
Drug: Intravenous methylprednisolone
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous methylprednisolone in addition to oral prednisolone therapy
Trial: 35513842
Drug: $333 monthly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: $333 monthly cash gift
Trial: 35513842
Drug: $20 monthly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: $20 monthly cash gift (Control)
Trial: 32706159
Drug: 10 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 g okra powder blended in 150 g conventional yogurt
Trial: 32269237
Drug: HOPE-L (Hypothermic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HOPE-L (Hypothermic Oxygenated Perfusion for Liver)
Trial: 32269237
Drug: SCS-L (Static
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SCS-L (Static Cold Storage for Liver)
Trial: 32269237
Drug: SCS-L
RxNorm normalized name: L-377202
DrugBank: L-377202 (DB19022)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SCS-L
Trial: 32269237
Drug: HOPE-L
RxNorm normalized name: L-377202
DrugBank: L-377202 (DB19022)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HOPE-L
Trial: 36068945
Drug: Keverprazan 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Keverprazan 30 mg
Trial: 34816682
Drug: Dienogest (Vissane
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dienogest (Vissane 2 mg tablet)
Trial: 33781234
Drug: Calcium 5
RxNorm normalized name: Calcium 500+D
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium 5 group (5 mg/kg calcium gluconate)
Trial: 33781234
Drug: Calcium 10
RxNorm normalized name: Calcium 10-undecenoate
DrugBank: Calcium undecylenate (DB15678)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium 10 group (10 mg/kg calcium gluconate)
Trial: 33402159
Drug: Metformin (with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (with lifestyle intervention)
Trial: 35617960
Drug: Informational video
RxNorm normalized name: INFORMATION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Informational video used to supplement standard in-person verbal and written consent
Trial: 35718205
Drug: VLA2001 high
RxNorm normalized name: HIGH DENSITY POLYETHYLENE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VLA2001 high dose
Trial: 34730529
Drug: Combined administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined administration of IV and local tranexamic acid
Trial: 33838657
Drug: Methylprednisolone (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone (2 mg/kg/day)
Trial: 33838657
Drug: Dexamethasone (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (6 mg/day)
Trial: 37145232
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of terlipressin (2 mg/day) and noradrenaline (starting at 0.5 mg/h, increased to 3 mg/h)
Trial: 33719268
Drug: Sham operation
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sham operation group (normal saline injection after tracheal exposure, n=10)
Trial: 35737855
Drug: 0.5 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg/day ETV
Trial: 35737855
Drug: 0.5 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg/day ETV maleate
Trial: 35986241
Drug: Pharmacist-led intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacist-led intervention (counselling with pictogram-enhanced medication instructions and smartphone medication reminders)
Trial: 32737072
Drug: Ozanimod HCl
RxNorm normalized name: ozanimod HCl
DrugBank: Ozanimod (DB12612)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Ozanimod HCl 0.5 mg/d
Trial: 32737072
Drug: Ozanimod HCl
RxNorm normalized name: ozanimod HCl
DrugBank: Ozanimod (DB12612)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Ozanimod HCl 1 mg/d
Trial: 34526429
Drug: Ranitidine Bismuth
RxNorm normalized name: RANITIDINE BISMUTH CITRATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine Bismuth Citrate (RBC) pretreatment for 2 weeks before standard triple therapy
Trial: 34526429
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment (esomeprazole, amoxicillin, and clarithromycin for 7 days)
Trial: 33022718
Drug: Control (Conventional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (Conventional treatments by atropine and pralidoxime)
Trial: 36201971
Drug: Lung recruitment
RxNorm normalized name: beef lung preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lung recruitment associated with positive end-expiratory pressure titration according to the best respiratory system compliance
Trial: 33210238
Drug: Physical activity
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical activity (greater average daily energy expenditure)
Trial: 35283083
Drug: Ibuprofen (median
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (median usage of 2 tablets of 800 mg)
Trial: 35283083
Drug: Oxycodone/acetaminophen (median
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone/acetaminophen (median usage of one-half of a 5/325mg tablet)
Trial: 35522872
Drug: Treatment for
RxNorm normalized name: Hair Regrowth Treatment For Men
DrugBank: Minoxidil (DB00350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Treatment for OA and diabetes mellitus according to international recommendations
Trial: 35522872
Drug: Treatment for
RxNorm normalized name: Hair Regrowth Treatment For Men
DrugBank: Minoxidil (DB00350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Treatment for OA and diabetes mellitus according to international recommendations + drug alpha-lipoic acid
Trial: 32381018
Drug: Eribulin (1.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eribulin (1.4 mg/m2 on days 1 and 8) with Tmab (8 mg/kg then 6 mg/kg) and Pmab (840 mg then 420 mg) on day 1 of each 21-day cycle